HTL0009936
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HTL0009936, covering 2016-10-18 to 2017-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects [Phase 1]